首页> 外文期刊>ACS medicinal chemistry letters >BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder
【24h】

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

机译:BMS-986163,GLUN2B的负变性调节剂,具有主要抑郁症的潜在效用

获取原文
获取原文并翻译 | 示例
           

摘要

机译:<![cdata [有重大的未满足的医疗需要更有效和快速作用的抗抑郁药。朝向该目的, N-甲基-D-天冬氨酸受体亚型GLUN2B的负变形调节剂已经证明了令人鼓舞的治疗潜力。我们在本文中报告了水溶性静脉注射药BMS-986163( 6)及其活性母体分子BMS-986169( 5)的发现和临床前曲线,其对GLUN2B变构位点显示出高结合亲和力( K _(i)= 4.0nm)和细胞中GLUN2B受体功能(IC_(50)= 24nm)的选择性抑制。前药 6至父母 5的转化在体外和体内跨前晶体。在静脉内给药后,化合物 5和 6表现出在啮齿动物中的靶啮合和小鼠中的抗抑郁药物的稳健水平。对于 5, 6或主要循环代谢物 Met-1和 Met-2,没有观察到明显的偏离靶活性。前药BMS-986163( 6)证明了可接受的安全性和毒理学谱,并选择作为主要抑郁症进一步评估的临床前候选者。]]>

著录项

  • 来源
    《ACS medicinal chemistry letters》 |2018年第5期|共6页
  • 作者单位

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Bristol-Myers Squibb Research and Development 3551 Lawrenceville Road Princeton New Jersey 08648 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Biocon Bristol-Myers Squibb Research Center Bangalore India;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

    Bristol-Myers Squibb Research and Development 5 Research Parkway Wallingford Connecticut 06492 United States;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;化学;
  • 关键词

    BMS-986163; BMS-986169; depression; GluN2B; ketamine; negative allosteric modulator; preclinical candidate;

    机译:BMS-986163;BMS-986169;抑郁症;GLUN2B;氯胺酮;负变性调节剂;临床前候选人;

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号